美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

减肥药

1,256.04

+10.480.84%

涨家数：6

跌家数：1

平家数：- -

市盈率：- -

高：1,272.13

开：1,246.00

低：1,240.72

收：1,245.53

数据加载中...

Altimmune, Inc.盘中异动股价大涨5.04%报4.07美元

安进盘中异动早盘股价大涨3.00%

从康辰药业KC1086看KAT6靶向药潜力：辉瑞、恒瑞等药企抢滩，或攻克CDK4/6耐药

CPHI制药在线

洞察力-诺和诺德如何误读美国市场对其减肥药的需求

【合作终止后减肥药后续供应成关键大摩给予予Hims & Hers Health(HIMS.US)“与大盘持平”评级】智

辉瑞6月30日成交额为10.85亿美元

诺和诺德6月30日成交额为5.27亿美元

23亿美元打水漂？辉瑞终止最后一项CD47明星实验

生物药大时代

安进6月30日成交额为8.26亿美元

媒体-美国众议院委员会传唤辉瑞公司前高管调查 Covid 疫苗延误指控 - CNN

摩根士丹利：诺和诺德潜在诉讼将成Hims & Hers关键考验

环球市场播报

Altimmune, Inc.盘中异动早盘急速下挫5.14%报3.32美元

安进公司的胃癌药物达到后期试验目标

辉瑞新型抗菌药物思福诺在华正式获批

辉瑞公司6月30日宣布新型抗菌药物思福诺（注射用氨曲南阿维巴坦钠以下简称“氨曲南/阿维巴坦”）获得国家药品监督管理局正式

五年后，谁将是全球最畅销的药？

【晶泰科技(02228.HK)与辉瑞深化战略合作，共建AI药物与新材料研发分子模拟平台】智通财经APP获悉，今天，全球领

晶泰科技宣布与辉瑞扩大战略合作共同开发全新一代的分子模拟平台以驱动新药研发。此次合作旨在进一步融合先进的物理算法的精确度

晶泰科技与辉瑞深化战略合作，共建AI药物与新材料研发分子模拟平台

币安将调整投资组合保证金抵押率

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/BK4599/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4599","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","market":"US","secType":"PLATE","nameCN":"减肥药","latestPrice":1256.0088,"timestamp":1751395573165,"preClose":1245.5326,"halted":0,"volume":59564359,"delay":0,"changeRate":0.008411,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":10.476196,"latestTime":"07-01 14:46:14 EDT","open":1245.9974,"high":1272.13,"low":1240.7244,"amount":3459395219.892978,"amplitude":0.025215,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1751400000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":9.522125,"peRate":31.546945,"turnoverRate":0.005629,"increases":6,"decrements":1,"flats":0,"marketCap":1348514735456,"floatMarketCap":1258720101248},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","high":1272.13,"amplitude":0.025215,"preClose":1245.5326,"low":1240.7244,"pbRate":"9.522125","latestPrice":1256.0378,"volume":59567532,"delay":0,"open":1245.9974,"prevYearClose":1305.0607,"prevWeekClose":1239.2252,"prevMonthClose":1245.5326,"prevQuarterClose":1245.5326,"fiveDayClose":1251.3418,"twentyDayClose":1229.9794,"sixtyDayClose":1265.6132,"secType":"PLATE","market":"US","turnoverRate":0.00563,"peRate":31.546945,"marketCap":1348522812768,"floatMarketCap":1258728194944,"timestamp":1751395577142,"nameCN":"减肥药"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4599\",,,,undefined,":{"bkCode":"BK4599","up":6,"down":1,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4599\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2548885578","title":"Altimmune, Inc.盘中异动 股价大涨5.04%报4.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548885578","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548885578?lang=zh_cn&edition=fundamental","pubTime":"2025-07-01 23:44","pubTimestamp":1751384667,"startTime":"0","endTime":"0","summary":"北京时间2025年07月01日23时44分，Altimmune, Inc.股票出现异动，股价快速上涨5.04%。截至发稿，该股报4.07美元/股，成交量502.514万股，换手率6.20%，振幅7.75%。Altimmune, Inc.股票所在的生物技术行业中，整体涨幅为1.04%。Altimmune, Inc.公司简介：Altimmune Inc 是一家处于临床阶段的生物制药公司，专注于开发针对肥胖症、代谢性疾病和肝脏疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701234428a4c94b67&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701234428a4c94b67&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1878469433.USD","BK4139","BK4599","ALT"],"gpt_icon":0},{"id":"2548000431","title":"安进盘中异动 早盘股价大涨3.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548000431","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548000431?lang=zh_cn&edition=fundamental","pubTime":"2025-07-01 22:39","pubTimestamp":1751380749,"startTime":"0","endTime":"0","summary":"北京时间2025年07月01日22时39分，安进股票出现波动，股价急速上涨3.00%。截至发稿，该股报287.58美元/股，成交量41.1249万股，换手率0.08%，振幅3.05%。安进股票所在的制药行业中，整体涨幅为0.91%。安进于 2006 年推出了首款癌症治疗药物 Vectibix，并销售骨强化药物 Prolia/Xgeva和 Evenity。同时，安进还拥有不断增长的生物仿制药产品组合。消息层面，截至22时39分，《TD Cowen维持安进买入评级，维持目标价389美元》资讯为影响安进的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701223909a728abc6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701223909a728abc6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2089984988.USD","BK4566","LU0320765992.SGD","IE0002141913.USD","LU2112291526.USD","LU2242652126.USD","BK4534","LU1061106388.HKD","IE00B4R5TH58.HKD","LU1571399168.USD","LU2468319806.SGD","LU2242646821.SGD","BK4599","IE00BFTCPJ56.SGD","SG9999001440.SGD","LU0058720904.USD","LU1983299246.USD","AMGN","IE00BJT1NW94.SGD","LU1023059063.AUD","IE0009355771.USD","LU0122379950.USD","IE00B2B36J28.USD","BK4139","IE00BJJMRZ35.SGD","LU0289739699.SGD","BK4533","LU0109394709.USD","BK4588","LU1057294990.SGD","LU0868494617.USD","BK4581","BK4585","LU0889565916.HKD"],"gpt_icon":0},{"id":"2548003569","title":"从康辰药业KC1086看KAT6靶向药潜力：辉瑞、恒瑞等药企抢滩，或攻克CDK4/6耐药","url":"https://stock-news.laohu8.com/highlight/detail?id=2548003569","media":"CPHI制药在线","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548003569?lang=zh_cn&edition=fundamental","pubTime":"2025-07-01 18:35","pubTimestamp":1751366118,"startTime":"0","endTime":"0","summary":"因此，KAT6被认为是肿瘤药研发的潜力靶点。此外，KAT6靶向药领域已有BD交易达成。总结整体来看，KAT6靶向药大多处于早期阶段，辉瑞的PF-07248144预计有望最先进入3期临床。适应症上看，当前KAT6靶向药主要集中在乳腺癌，有望攻克CDK4/6抑制剂耐药问题。期待KAT6靶向药早日迎来重大突破，造福广大肿瘤患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701185313a4c8d3e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701185313a4c8d3e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","BK4568","LU0456855351.SGD","LU1894683348.USD","SG9999002224.SGD","LU0122379950.USD","SG9999013999.USD","LU0985481810.HKD","IE00B19Z3581.USD","LU0321505439.SGD","LU1066051498.USD","BK4581","BK4007","IE0002270589.USD","SG9999003800.SGD","603590","01276","SGXZ57979304.SGD","LU0234572021.USD","PFE","LU1883839398.USD","BK4533","BK4585","LU0170899867.USD","LU0306807586.USD","BK4588","LU1066053197.SGD","SG9999011175.SGD","BK4534","IE00BLSP4239.USD","LU1057294990.SGD","SG9999001176.SGD","IE000M9KFDE8.USD","LU1023059063.AUD","BK4592","IE00BBT3K403.USD","SG9999002232.USD","LU0058720904.USD","LU0289739699.SGD","BK4550","LU0868494617.USD","LU1894683264.USD","IE00B19Z3B42.SGD","LU0225284248.USD","LU0225771236.USD","IE00BLSP4452.SGD","LU0306806265.USD","LU0321505868.SGD","SG9999001176.USD","600276"],"gpt_icon":1},{"id":"2548109077","title":"洞察力-诺和诺德如何误读美国市场对其减肥药的需求","url":"https://stock-news.laohu8.com/highlight/detail?id=2548109077","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548109077?lang=zh_cn&edition=fundamental","pubTime":"2025-07-01 18:00","pubTimestamp":1751364006,"startTime":"0","endTime":"0","summary":"洞察力-诺和诺德如何误读美国市场对其减肥药的需求诺和诺德就 Wegovy 的上市准备情况发出内部警告礼来的 Zepbound 在新增处方量上超过了 Wegovy诺和诺德的定价策略引起了保险公司和患者的反感Jacob Gronholt-Pedersen/Maggie Fick. 关于诺和诺德内部讨论的细节，此前并无报道。四名前员工表示，其他表明对Wegovy有大量需求的迹象包括医生反馈和Ozempic的处方数据，Ozempic是诺和诺德的糖尿病药物，含有与Wegovy相同的活性成分。Leu 的基金同时持有诺和诺德和礼来的股票。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250701:nL4S3SY0PQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1280957306.USD","LU0820561909.HKD","LU0882574139.USD","LU2264538146.SGD","LU0234572021.USD","LU0672654240.SGD","LU2237443382.USD","LU2552382058.USD","SG9999001176.USD","LU0466842654.USD","LU1093756168.USD","LU2360106947.USD","SGXZ57979304.SGD","IE00B4R5TH58.HKD","LU1551013425.SGD","LU0058720904.USD","LU2461242641.AUD","LU2237443549.SGD","LU1093756325.SGD","LU1291159041.SGD","LU0109394709.USD","LU2106854487.HKD","LU0256863811.USD","LU2265009873.SGD","IE00BK4W5L77.USD","LU2417539215.USD","SG9999018857.SGD","LU2750360997.AUD","SG9999015986.USD","LU0943347566.SGD","LU2063271972.USD","BK4581","IE0004445239.USD","BK4599","LU2456880835.USD","LU0320765992.SGD","LU0203201768.USD","IE00BJLML261.HKD","SG9999001176.SGD","SG9999015945.SGD","LU0354030511.USD","LU2750360641.GBP","LU0114720955.EUR","LU0471298694.HKD","LU1814569148.SGD","LU2361045086.USD","LU2471134796.USD","LU1983299246.USD","LU1023059063.AUD"],"gpt_icon":1},{"id":"2548075112","title":"【合作终止后减肥药后续供应成关键 大摩给予予Hims & Hers Health(HIMS.US)“与大盘持平”评级】智","url":"https://stock-news.laohu8.com/highlight/detail?id=2548075112","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548075112?lang=zh_cn&edition=fundamental","pubTime":"2025-07-01 15:50","pubTimestamp":1751356243,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4127","LU0971096721.USD","LU2089284900.SGD","BK4534","LU0106261372.USD","LU0795875086.SGD","LU1363072403.SGD","LU0320765646.SGD","LU0912757837.SGD","LU2028103732.USD","LU0006306889.USD","LU1989772923.USD","LU0158827948.USD","HIMS","LU1720051017.SGD","LU1093756168.USD","LU0154236417.USD","IE00BZ1G4Q59.USD","BK4532","BK4516","LU0158827781.USD","IE00BKVL7J92.USD","LU1093756325.SGD","BK4504","LU2089283258.USD","LU2111349929.HKD","LU0234570918.USD","LU0267386448.USD","LU2271345857.HKD","LU0106831901.USD","LU2023251221.USD","LU1548497426.USD","BK4196","BK4007","LU0795875169.SGD","LU1162221912.USD","BK4599","LU1668664300.SGD","NVO","LU2133065610.SGD","BK4588","159891","LU0098860793.USD","LU1720051108.HKD","LU2357305700.SGD","LU2347655156.SGD","LU1989772840.SGD","LU1732800096.USD","LU0314104364.USD","LU0225283273.USD"],"gpt_icon":0},{"id":"2548336029","title":"辉瑞6月30日成交额为10.85亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548336029","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548336029?lang=zh_cn&edition=fundamental","pubTime":"2025-07-01 12:29","pubTimestamp":1751344147,"startTime":"0","endTime":"0","summary":"美东时间2025年6月30日，辉瑞成交额为10.85亿美元，成交额较昨日增加13.19%，当日成交量为4473.09万股。辉瑞于2025年6月30日涨0.21%，报24.24美元，该股过去5个交易日涨0.87%，年初至今跌5.35%，过去60日涨0.01%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-06-30|10.85亿|13.19%|4473.09万|#|2025-06-27|9.58亿|23.98%|3952.88万|#|2025-06-26|7.73亿|24.58%|3183.53万|#|2025-06-25|6.21亿|-25.69%|2560.33万|#|2025-06-24|8.35亿|9.14%|3440.42万|辉瑞是全球最大的制药公司之一，年销售额接近500亿美元。辉瑞在全球销售这些产品，国际销售额占其总销售额的近50%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701122913a4c813a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701122913a4c813a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0321505439.SGD","BK4568","IE00BLSP4239.USD","BK4550","SGXZ57979304.SGD","LU1066053197.SGD","BK4534","IE00B19Z3B42.SGD","LU1894683348.USD","IE0002270589.USD","LU0170899867.USD","LU0225284248.USD","LU0985481810.HKD","LU1894683264.USD","IE00B19Z3581.USD","IE000M9KFDE8.USD","BK4599","SG9999001176.SGD","SG9999002224.SGD","SG9999001176.USD","LU0306806265.USD","LU0058720904.USD","LU0306807586.USD","BK4007","LU1066051498.USD","SG9999011175.SGD","LU0456855351.SGD","LU1023059063.AUD","SG9999013999.USD","BK4592","LU0225771236.USD","LU1883839398.USD","IE00BBT3K403.USD","LU0122379950.USD","PFE","LU0234572021.USD","LU0289739699.SGD","SG9999003800.SGD","BK4533","SG9999002232.USD","BK4588","LU1057294990.SGD","LU0321505868.SGD","LU0868494617.USD","IE00BLSP4452.SGD","BK4581","BK4585"],"gpt_icon":0},{"id":"2548674029","title":"诺和诺德6月30日成交额为5.27亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548674029","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548674029?lang=zh_cn&edition=fundamental","pubTime":"2025-07-01 12:06","pubTimestamp":1751342781,"startTime":"0","endTime":"0","summary":"美东时间2025年6月30日，诺和诺德成交额为5.27亿美元，成交额较昨日增加36.61%，当日成交量为763.74万股。诺和诺德于2025年6月30日涨0.74%，报69.02美元，该股过去5个交易日跌1.0%，年初至今跌18.68%，过去60日涨1.14%。诺和诺德还有一个生物制药部门，专门从事血友病和其他疾病的蛋白质疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701120624a7278315&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701120624a7278315&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4532","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","LU1093756325.SGD","LU1093756168.USD","NVO","BK4588","BK4585","BK4007","LU0154236417.USD","BK4599"],"gpt_icon":1},{"id":"2548202840","title":"23亿美元打水漂？辉瑞终止最后一项CD47明星实验","url":"https://stock-news.laohu8.com/highlight/detail?id=2548202840","media":"生物药大时代","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548202840?lang=zh_cn&edition=fundamental","pubTime":"2025-07-01 10:32","pubTimestamp":1751337151,"startTime":"0","endTime":"0","summary":"6月30日，据外媒报道，辉瑞已经终止CD47 项目中maplirpacept 与化疗药物来那度胺联合用于复发或难治性弥漫性大B细胞淋巴瘤患者的2期研究。发言人表示，终止该研究是由于“招募受阻，并非安全或疗效翻车”。TTI-622是2021年辉瑞斥资22.6亿美元收购Trillium公司而获得的第2个CD47项目，另一个是TTI-621，此前辉瑞已经停止TTI-621的开发，这意味着辉瑞收购而来的两条CD47路线全部按下暂停键。TTI-621 和 TTI-622 结构CD47 曾经是新癌症药物的有前途的靶点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701103523a4c7db5f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701103523a4c7db5f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1057294990.SGD","LU0306806265.USD","IE00B19Z3B42.SGD","SG9999003800.SGD","BK4533","IE00B19Z3581.USD","BK4534","LU1894683348.USD","LU0321505439.SGD","BK4581","SG9999002232.USD","LU0058720904.USD","LU1066051498.USD","LU1883839398.USD","LU0234572021.USD","SG9999001176.SGD","SG9999011175.SGD","IE000M9KFDE8.USD","LU0868494617.USD","BK4568","IE0002270589.USD","BK4588","LU0170899867.USD","LU0225771236.USD","IE00BLSP4452.SGD","BK4007","LU1066053197.SGD","SG9999013999.USD","BK4550","SG9999001176.USD","LU0456855351.SGD","LU0122379950.USD","LU0306807586.USD","LU0225284248.USD","LU1023059063.AUD","BK4599","IE00BLSP4239.USD","PFE","SGXZ57979304.SGD","SG9999002224.SGD","BK4592","LU0985481810.HKD","IE00BBT3K403.USD","LU1894683264.USD","LU0321505868.SGD","LU0289739699.SGD","BK4585"],"gpt_icon":0},{"id":"2548204225","title":"安进6月30日成交额为8.26亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548204225","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548204225?lang=zh_cn&edition=fundamental","pubTime":"2025-07-01 09:16","pubTimestamp":1751332574,"startTime":"0","endTime":"0","summary":"美东时间2025年6月30日，安进成交额为8.26亿美元，成交额较昨日增加2.71%，当日成交量为296.39万股。安进于2025年6月30日涨0.75%，报279.21美元，该股过去5个交易日涨2.48%，年初至今涨8.95%，过去60日跌7.85%。安进于 2006 年推出了首款癌症治疗药物 Vectibix，并销售骨强化药物 Prolia/Xgeva和 Evenity。同时，安进还拥有不断增长的生物仿制药产品组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701091621a727295b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701091621a727295b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1057294990.SGD","SG9999001440.SGD","IE00BFTCPJ56.SGD","AMGN","BK4533","BK4534","LU0109394709.USD","BK4581","LU0058720904.USD","IE00BJT1NW94.SGD","LU1571399168.USD","LU0868494617.USD","IE00B4R5TH58.HKD","LU1983299246.USD","LU2242652126.USD","LU2242646821.SGD","BK4588","LU2089984988.USD","LU0320765992.SGD","LU2112291526.USD","LU0122379950.USD","LU2468319806.SGD","IE0009355771.USD","LU0889565916.HKD","LU1061106388.HKD","BK4566","LU1023059063.AUD","BK4599","BK4139","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","IE0002141913.USD","LU0289739699.SGD","BK4585"],"gpt_icon":0},{"id":"2548542017","title":"媒体-美国众议院委员会传唤辉瑞公司前高管调查 Covid 疫苗延误指控 - CNN","url":"https://stock-news.laohu8.com/highlight/detail?id=2548542017","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548542017?lang=zh_cn&edition=fundamental","pubTime":"2025-07-01 03:46","pubTimestamp":1751312818,"startTime":"0","endTime":"0","summary":"媒体-美国众议院委员会传唤辉瑞公司前高管调查 Covid 疫苗延误指控 - CNN6月30日 -  -- 来源链接： https://tinyurl.com/yxp4bw7s  -- 注：路透未核实此报导，不保证其准确性(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250630:nL4T3SX1DY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0321505439.SGD","BK4568","IE00BLSP4239.USD","BK4550","SGXZ57979304.SGD","LU1066053197.SGD","BK4534","IE00B19Z3B42.SGD","LU1894683348.USD","IE0002270589.USD","LU0170899867.USD","LU0225284248.USD","LU0985481810.HKD","LU1894683264.USD","IE00B19Z3581.USD","IE000M9KFDE8.USD","BK4599","SG9999001176.SGD","SG9999002224.SGD","SG9999001176.USD","LU0306806265.USD","LU0058720904.USD","LU0306807586.USD","BK4007","LU1066051498.USD","SG9999011175.SGD","LU0456855351.SGD","LU1023059063.AUD","SG9999013999.USD","BK4592","LU0225771236.USD","LU1883839398.USD","IE00BBT3K403.USD","LU0122379950.USD","PFE","LU0234572021.USD","LU0289739699.SGD","SG9999003800.SGD","BK4533","SG9999002232.USD","BK4588","LU1057294990.SGD","LU0321505868.SGD","LU0868494617.USD","IE00BLSP4452.SGD","BK4581","BK4585"],"gpt_icon":0},{"id":"2547015271","title":"摩根士丹利：诺和诺德潜在诉讼将成Hims & Hers关键考验","url":"https://stock-news.laohu8.com/highlight/detail?id=2547015271","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547015271?lang=zh_cn&edition=fundamental","pubTime":"2025-06-30 23:35","pubTimestamp":1751297758,"startTime":"0","endTime":"0","summary":"摩根士丹利分析师在研报中指出，Hims & Hers Health面临的核心问题在于，若诺和诺德对其发起诉讼，该公司能否继续提供复合式GLP-1药物疗法。\n　　本月早些时候，诺和诺德突然终止与Hims & Hers的合作关系，指控其非法销售廉价版Wegovy减肥药仿制品并实施虚假营销。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：王许宁","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2025-06-30/doc-infcwqxy9535251.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina_us","symbols":["LU0314104364.USD","LU0158827781.USD","LU1720051108.HKD","LU1162221912.USD","BK4534","BK4532","LU0106831901.USD","LU0225283273.USD","LU0158827948.USD","LU2089283258.USD","BK4581","LU0320765646.SGD","LU2028103732.USD","LU2133065610.SGD","LU0234570918.USD","LU1732800096.USD","BK4504","LU1093756168.USD","LU2089284900.SGD","LU1989772840.SGD","LU0267386448.USD","LU0106261372.USD","LU0971096721.USD","LU2023251221.USD","NVO","IE00BKVL7J92.USD","LU1989772923.USD","LU2111349929.HKD","MS","LU1720051017.SGD","LU0098860793.USD","LU0154236417.USD","LU0912757837.SGD","LU2357305700.SGD","LU1074936037.SGD","BK4588","BK4585","LU2271345857.HKD","LU1093756325.SGD","LU2347655156.SGD","BK4516","IE00BZ1G4Q59.USD","LU1668664300.SGD","LU1363072403.SGD","BK4599","LU1548497426.USD","LU0795875169.SGD","LU0006306889.USD","BK4007","LU0795875086.SGD"],"gpt_icon":0},{"id":"2547097800","title":"Altimmune, Inc.盘中异动 早盘急速下挫5.14%报3.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2547097800","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547097800?lang=zh_cn&edition=fundamental","pubTime":"2025-06-30 21:38","pubTimestamp":1751290731,"startTime":"0","endTime":"0","summary":"北京时间2025年06月30日21时38分，Altimmune, Inc.股票出现波动，股价快速跳水5.14%。Altimmune, Inc.股票所在的生物技术行业中，整体涨幅为0.15%。其相关个股中，Artelo Biosciences, Inc.、Klotho Neurosciences, Inc.、Liminatus Pharma Inc C/Wts 30/04/2030 涨幅较大，Artelo Biosciences, Inc.、Klotho Neurosciences, Inc.、Inmune Bio Inc.较为活跃，换手率分别为2139.23%、124.12%、70.55%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Galectin Therapeutics Inc.、Cognition Therapeutics, Inc.，振幅分别为131.52%、111.02%、109.17%。Altimmune, Inc.公司简介：Altimmune Inc 是一家处于临床阶段的生物制药公司，专注于开发针对肥胖症、代谢性疾病和肝脏疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630213851a4c6c7d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630213851a4c6c7d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1878469433.USD","BK4139","BK4599","ALT"],"gpt_icon":0},{"id":"2547094085","title":"安进公司的胃癌药物达到后期试验目标","url":"https://stock-news.laohu8.com/highlight/detail?id=2547094085","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547094085?lang=zh_cn&edition=fundamental","pubTime":"2025-06-30 21:06","pubTimestamp":1751288762,"startTime":"0","endTime":"0","summary":"安进公司的胃癌药物达到后期试验目标路透6月30日 - 安进公司（Amgen AMGN.O）周一表示，其实验性癌症疗法与化疗相结合，在一项晚期试验中达到了主要目标。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250630:nL4S3SX0YF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","LU1023059063.AUD","IE00BJJMRZ35.SGD","LU2468319806.SGD","BK4588","IE00BJT1NW94.SGD","LU1057294990.SGD","BK4581","BK4599","LU2112291526.USD","IE0002141913.USD","BK4534","LU1061106388.HKD","LU2089984988.USD","LU2242646821.SGD","BK4533","BK4585","IE00B2B36J28.USD","SG9999001440.SGD","LU0889565916.HKD","BK4566","IE00B4R5TH58.HKD","LU0058720904.USD","LU0868494617.USD","LU2242652126.USD","LU1983299246.USD","LU0320765992.SGD","LU0122379950.USD","BK4139","LU1571399168.USD","IE00BFTCPJ56.SGD","LU0109394709.USD","LU0289739699.SGD","AMGN"],"gpt_icon":0},{"id":"2547103047","title":"辉瑞新型抗菌药物思福诺在华正式获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2547103047","media":"格隆汇","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547103047?lang=zh_cn&edition=fundamental","pubTime":"2025-06-30 11:23","pubTimestamp":1751253814,"startTime":"0","endTime":"0","summary":"格隆汇6月30日｜辉瑞公司今日宣布，新型抗菌药物思福诺®(注射用氨曲南阿维巴坦钠)获得国家药品监督管理局正式批准，用于治疗由革兰阴性菌引起的治疗药物选择有限或无替代治疗的成人复杂性腹腔内感染(cIAI)，医院获得性肺炎(HAP)，包括呼吸机相关性肺炎(VAP)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506301124109530bc49&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506301124109530bc49&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999013999.USD","BK4592","LU0225284248.USD","SG9999011175.SGD","BK4585","IE00BLSP4452.SGD","LU1883839398.USD","IE0002270589.USD","LU0289739699.SGD","LU0985481810.HKD","LU1066053197.SGD","IE000M9KFDE8.USD","BK4568","BK4581","LU0306807586.USD","SG9999003800.SGD","LU0321505868.SGD","LU1894683264.USD","BK4007","LU0122379950.USD","LU1023059063.AUD","BK4599","LU0306806265.USD","LU1057294990.SGD","SG9999002224.SGD","BK4533","IE00B19Z3581.USD","LU1066051498.USD","IE00B19Z3B42.SGD","BK4588","LU0170899867.USD","IE00BBT3K403.USD","LU0234572021.USD","BK4534","PFE","IE00BLSP4239.USD","LU0058720904.USD","SG9999001176.SGD","LU0456855351.SGD","LU0225771236.USD","LU1894683348.USD","LU0321505439.SGD","SG9999002232.USD","SG9999001176.USD","LU0868494617.USD","BK4550","SGXZ57979304.SGD"],"gpt_icon":0},{"id":"2547030149","title":"辉瑞公司6月30日宣布新型抗菌药物思福诺（注射用氨曲南阿维巴坦钠以下简称“氨曲南/阿维巴坦”）获得国家药品监督管理局正式","url":"https://stock-news.laohu8.com/highlight/detail?id=2547030149","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547030149?lang=zh_cn&edition=fundamental","pubTime":"2025-06-30 11:18","pubTimestamp":1751253508,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0868494617.USD","LU0985481810.HKD","LU0058720904.USD","LU1066051498.USD","LU0170899867.USD","IE00BLSP4452.SGD","LU1066053197.SGD","LU1894683264.USD","PFE","BK4533","BK4568","LU0225284248.USD","IE00BBT3K403.USD","BK4581","BK4550","SG9999001176.SGD","LU0289739699.SGD","BK4007","HAP","LU0234572021.USD","BK4585","IE0002270589.USD","IE00BLSP4239.USD","SG9999011175.SGD","SG9999002232.USD","SGXZ57979304.SGD","SG9999002224.SGD","LU1883839398.USD","LU1023059063.AUD","BK4588","LU0306807586.USD","BK4599","IE000M9KFDE8.USD","SG9999013999.USD","LU0306806265.USD","SG9999003800.SGD","LU0225771236.USD","BK4592","IE00B19Z3B42.SGD","LU0321505439.SGD","LU1894683348.USD","LU0456855351.SGD","SG9999001176.USD","LU0321505868.SGD","BK4534","LU1057294990.SGD","LU0122379950.USD","IE00B19Z3581.USD"],"gpt_icon":0},{"id":"2547303084","title":"五年后，谁将是全球最畅销的药？","url":"https://stock-news.laohu8.com/highlight/detail?id=2547303084","media":"药智网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547303084?lang=zh_cn&edition=fundamental","pubTime":"2025-06-30 10:47","pubTimestamp":1751251653,"startTime":"0","endTime":"0","summary":"2030年全球最畅销药物排行榜到2030年，受糖尿病与肥胖症药物持续热销的推动，礼来将跃居全球处方药销售榜首，其处方药年销售额预计将达到1126亿美元，遥遥领先于排名第二、销售额预计为839亿美元的诺和诺德。诺和诺德的Cagrisema高居榜首，净现值高达800亿美元，2030年全球销售额预计将达152亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630105229a4c57c44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630105229a4c57c44&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BBT3K403.USD","LU1804176565.USD","LU0198837287.USD","NPV","LU0265550946.USD","SGXZ57979304.SGD","LU0238689110.USD","LU2063271972.USD","IE00BJT1NW94.SGD","SGXZ51526630.SGD","MRK","LU1061106388.HKD","LU1162221912.USD","AZN","SG9999013999.USD","SG9999014559.SGD","LU1430594728.SGD","BK4533","LU2602419157.SGD","LU0861579265.USD","LU1868836914.USD","LU1116320901.HKD","LU0097036916.USD","LU2456880835.USD","LU0689472784.USD","NVO","LU0006306889.USD","LU2552382132.HKD","SG9999001440.SGD","BK4007","LU1929549753.HKD","IE00B1BXHZ80.USD","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","LU1941712264.USD","LU1720051108.HKD","IE00BJLML261.HKD","LU2491050071.SGD","LU0823416689.USD","LU0203202063.USD","SG9999017495.SGD","SGXZ31699556.SGD","LU0096364046.USD","BK4599","LLY","LU2211815571.USD","LU2264538146.SGD","IE00BK4W5L77.USD","SG9999014914.USD","SG9999002232.USD","LU2361045086.USD"],"gpt_icon":1},{"id":"2547324790","title":"【晶泰科技(02228.HK)与辉瑞深化战略合作，共建AI药物与新材料研发分子模拟平台】智通财经APP获悉，今天，全球领","url":"https://stock-news.laohu8.com/highlight/detail?id=2547324790","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547324790?lang=zh_cn&edition=fundamental","pubTime":"2025-06-30 10:21","pubTimestamp":1751250105,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0985481810.HKD","PFE","SG9999002224.SGD","IE00B19Z3B42.SGD","BK4533","BK4599","LU0122379950.USD","SG9999013999.USD","LU0234572021.USD","LU0321505439.SGD","BK4592","BK1617","LU0225771236.USD","BK4007","LU0058720904.USD","LU0225284248.USD","LU0289739699.SGD","02228","BK4581","LU0321505868.SGD","SGXZ57979304.SGD","LU1066051498.USD","LU1057294990.SGD","SG9999003800.SGD","LU1883839398.USD","LU0868494617.USD","SG9999002232.USD","BK1141","LU0306807586.USD","LU1894683348.USD","LU1894683264.USD","IE000M9KFDE8.USD","159703","SG9999001176.SGD","IE00BLSP4239.USD","SG9999001176.USD","BK4568","IE00B19Z3581.USD","BK4585","BK4550","LU0170899867.USD","IE00BLSP4452.SGD","LU0306806265.USD","LU1066053197.SGD","LU0456855351.SGD","IE0002270589.USD","BK4588","LU1023059063.AUD","SG9999011175.SGD","IE00BBT3K403.USD"],"gpt_icon":0},{"id":"2547349860","title":"晶泰科技宣布与辉瑞扩大战略合作共同开发全新一代的分子模拟平台以驱动新药研发。此次合作旨在进一步融合先进的物理算法的精确度","url":"https://stock-news.laohu8.com/highlight/detail?id=2547349860","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547349860?lang=zh_cn&edition=fundamental","pubTime":"2025-06-30 09:54","pubTimestamp":1751248489,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0234572021.USD","LU1023059063.AUD","LU0306806265.USD","SG9999001176.SGD","BK4588","LU1057294990.SGD","PFE","SG9999002224.SGD","BK4581","IE00B19Z3581.USD","IE00B19Z3B42.SGD","BK4599","LU0170899867.USD","LU0321505868.SGD","IE00BBT3K403.USD","LU0321505439.SGD","BK4534","LU1066051498.USD","LU1883839398.USD","IE000M9KFDE8.USD","LU0225284248.USD","LU0456855351.SGD","BK4533","BK4585","IE0002270589.USD","BK4592","SGXZ57979304.SGD","SG9999013999.USD","BK4550","BK4007","LU0225771236.USD","LU0058720904.USD","LU0868494617.USD","LU1894683264.USD","02228","LU1894683348.USD","SG9999001176.USD","SG9999011175.SGD","LU0122379950.USD","SG9999002232.USD","IE00BLSP4452.SGD","SG9999003800.SGD","BK1141","BK4568","LU0985481810.HKD","LU1066053197.SGD","BK1617","LU0289739699.SGD","LU0306807586.USD","IE00BLSP4239.USD"],"gpt_icon":0},{"id":"2547031978","title":"晶泰科技与辉瑞深化战略合作，共建AI药物与新材料研发分子模拟平台","url":"https://stock-news.laohu8.com/highlight/detail?id=2547031978","media":"动脉网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547031978?lang=zh_cn&edition=fundamental","pubTime":"2025-06-30 09:11","pubTimestamp":1751245860,"startTime":"0","endTime":"0","summary":"晶泰科技与辉瑞扩大合作，共建AI驱动的分子模拟平台，提升药物研发效率、精度，覆盖更广化学空间，加速小分子药物发现与开发进程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506300942279530a205&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506300942279530a205&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0225771236.USD","LU0289739699.SGD","SGXZ57979304.SGD","LU0456855351.SGD","LU1066053197.SGD","BK4007","IE00BLSP4239.USD","LU1883839398.USD","BK4550","LU0170899867.USD","LU1894683348.USD","SG9999001176.SGD","BK4592","LU0985481810.HKD","LU0225284248.USD","LU0306807586.USD","LU0868494617.USD","BK4581","SG9999001176.USD","SG9999002224.SGD","IE00B19Z3581.USD","LU0122379950.USD","BK4568","LU1023059063.AUD","SG9999011175.SGD","LU0321505868.SGD","BK4599","LU0321505439.SGD","LU0234572021.USD","LU0306806265.USD","IE00B19Z3B42.SGD","LU1894683264.USD","BK4534","IE000M9KFDE8.USD","BK4533","LU1057294990.SGD","IE00BLSP4452.SGD","LU0058720904.USD","BK4585","IE00BBT3K403.USD","BK4588","IE0002270589.USD","SG9999002232.USD","SG9999003800.SGD","PFE","SG9999013999.USD","LU1066051498.USD"],"gpt_icon":0},{"id":"2547084946","title":"币安将调整投资组合保证金抵押率","url":"https://stock-news.laohu8.com/highlight/detail?id=2547084946","media":"Odaily","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547084946?lang=zh_cn&edition=fundamental","pubTime":"2025-06-29 22:46","pubTimestamp":1751208360,"startTime":"0","endTime":"0","summary":"Odaily星球日报讯 据官方公告，币安将于 2025 年 07 月 04 日 06：00（UTC）调整投资组合保证金模式下部分资产的抵押率，涉及 OP、CRV、CAKE、ENS、RUNE、ROSE、ORDI、SUSHI、ONE、ALT、MANTA 等币种。 （本条快讯由AI辅助生成）","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.odaily.news/newsflash/436781?source=share","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"odaily_live","symbols":["BK4139","BK4096","159001","BK4209","BK4599","CAKE","ALT","ENS","OP.USD.HKCC","OP","ROSE","LU1878469433.USD","BK4021"],"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":1,"totalSize":166,"code":"91000000","status":"200"}]}}